Sign Up to like & get
recommendations!
0
Published in 2020 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2020.584959
Abstract: PD-1/PD-L1 pathway plays a role in inhibiting immune response. Therapeutic antibodies aimed at blocking the PD-1/PD-L1 interaction have entered clinical development and have been approved for a variety of cancers. However, the clinical benefits are…
read more here.
Keywords:
melanoma;
caesalpinia spinosa;
response;
effect ... See more keywords